Navigation Links
2011 Consensus Panel Issues New Guidelines for Intrathecal Pain Management
Date:12/19/2011

DUBLIN, Dec. 19, 2011 /PRNewswire/ -- A panel of experts has recommended changes to the guidelines used to determine treatment via intrathecal administration for patients suffering from severe chronic pain. The 2011 Polyanalgesic Consensus Conference (PACC) brought together a group of national leaders in chronic pain management for the purpose of updating their current algorithm to standardize decision-making among providers and improving the technical quality of care in chronic pain.

The 2011 PACC guidelines for management of nociceptive and neuropathic chronic pain by intrathecal drug delivery recommended ziconotide, among other drugs, as a first-line intrathecal treatment. The panel recognized that ziconotide should be titrated in a low and slow manner. Ziconotide was also recommended by the 2011 group as the preferred option for intrathecal administration compared to opioids when there is a concern for recurrent granuloma. [please see important safety information and product indication at the end of this release]

The expert panel recommendation was based on an extensive literature search and an expansive survey with more than 15,000 clinicians worldwide since the last update in 2007.  The panel also reviewed changes in the FDA status of medications and their combined clinical expertise to inform their recommendations

"The Consensus Conference was convened to review the importance of drug selection in patient outcomes; to review issues concerning granuloma detection, prevention and treatment; to consider trialing methods and candidates and to consider best practices to reduce morbidity and mortality," said Tim Deer, MD, president and CEO, The Center for Pain Relief and Clinical Professor of Anesthesiology, West Virginia University School of Medicine, Charleston, WV.

The expert panel of 29 clinicians and the faculty of the North American Neuromodulation Society was convened by Tim Deer, MD, Joshua Prager, MD, MS, Center for t
'/>"/>

SOURCE Azur Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use
2. Agendias Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations
3. Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
4. Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
10. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
11. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 25, 2014  Array BioPharma ... announced that its Chief Executive Officer, ... following upcoming conferences.  The public is welcome ... on the Array BioPharma website:  www.arraybiopharma.com ... 2014Time:1:30 p.m.  Eastern Time Location: Palace Hotel, ...
(Date:11/26/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 3, 2014 ... Helen Torley , President and Chief Executive Officer, will provide ... through the "Investors" section of Halozyme,s corporate website at ... 90 days following the event. To access the live webcast, ...
(Date:11/24/2014)... 2014 Juno Therapeutics today announced that ... the company,s JCAR015 chimeric antigen receptor product candidate. ... or refractory B-cell acute lymphoblastic leukemia and was ... Cancer Center, where Phase 1 clinical trials are ... is important news for patients who may benefit ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3
... 16 Announced on November 06, 2009 by Mr. Mark ... and the Board of MEGGLE Group of Wasserburg, Germany, represented ... Christian Sedlatschek, CFO, the companies are entering a long-term partnership ... , DAVISCO Foods is an international cheese and food ingredient ...
... INDIANAPOLIS, Nov. 16 AMD LASERS, the world leader ... the addition of Bart Waclawik as Chief Operating Officer. ... responsible for daily global operations, procurement, production, quality assurance, ... will lead the engineering effort on the next-generation of ...
Cached Medicine Technology:DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose. 2AMD LASERS Announces the Addition of Bart Waclawik, New Chief Operating Officer 2
(Date:11/26/2014)... Kansas (PRWEB) November 26, 2014 ... will showcase expanded capabilities at RSNA 2014 in ... access, manage and share diagnostic images, photos, videos ... to Perceptive’s booth #8107 will learn more about ... newly acquired technologies and partner initiatives – that ...
(Date:11/26/2014)... One of the most important and vital ... her life is choosing the ideal wedding dress and ... to purchase high quality outfits. Today, BellasDress.com has unveiled ... can pick their suitable bridesmaid gowns here at discount ... ladies look scintillating and highlight all their most beautiful ...
(Date:11/26/2014)... TUESDAY, Nov. 25, 2014 (HealthDay News) -- Vultures have ... bacteria they ingest when eating dead animals, researchers report. ... bacteria found on the faces and in the guts ... United States. On average, the faces of the vultures ... with 76 in their guts, the study found. ...
(Date:11/26/2014)... -- The number of emergency department visits in the United ... record 136 million in 2011, according to the U.S. Centers ... that fewer people were going to ERs with non-urgent medical ... care within two hours of arriving at the ER. In ... Sixty percent of patients arrived at the ER after ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. 25, 2014 ... Food and Drug Administration will have many restaurant chains posting ... to movie theater popcorn and ice cream parlor fare. ... home, often consuming less nutritious food and underestimating the calories ... Monday afternoon news conference. Although listing calorie counts ...
Breaking Medicine News(10 mins):Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Royal Blue Bridesmaid Dresses Now Are Available for Christmas at BellasDress.com 2Health News:ER Visits on the Rise, Study Reports 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 3
... CLEVELAND, Aug. 25 As part of Jani-King International, the world,s ... have been recognized as part of the Corporate and Regional Office ... The IBA selected Jani-King,s entry as the winner for 2009. ... countries, including first-time winners from Japan, New Zealand, and Poland, were ...
... , , , ... ., makers of the patented probiotic strain Ganeden BC30 (R), today announced ... a leading U.S. importer-producer of private label and branded Italian pasta. ... probiotic-enhanced pasta available to consumers. , , The ...
... , , LONDON, Aug. 25 ... of patients - and make the wound care market a billion ... when appropriate treatment is not provided. Market players in the wound ... on the patient, in order to be able to develop more ...
... MILWAUKEE, Aug. 25 Worries about the H1N1 virus haven,t ... Bradley Corporation, a leading manufacturer of commercial bathroom and locker room ... Washing Survey, 54 percent said they "wash their hands no more ... , , "We were extremely surprised by that ...
... , , NEW YORK, Aug. 25 babyUV/kidsUV inc. ... "kidsUV Surf Team" brand. This new line is geared towards older kids ... on display at the KIDShow Las Vegas from August 31 to September ... to expand into a growing market of concerned parents wanting to protect ...
... , , 5,622 Families ... MIAMI, Aug. 25 Miami-Dade County Mayor Alvarez has eliminated all ... 2009. The proposed would mean the total elimination of over $31 ... significant portion of the CBO cuts would apply to Institute for ...
Cached Medicine News:Health News:Jani-King Recognized as Best in Support by the International Business Awards 2Health News:Ganeden Biotech, Racconto Introduce First Probiotic Pasta Line 2Health News:Ganeden Biotech, Racconto Introduce First Probiotic Pasta Line 3Health News:A Wound that Does Not Heal: Frost & Sullivan Reveals the Impact of Chronic Ulcers on the European Healthcare System 2Health News:Despite H1N1 Flu Threat, Most Americans Haven't Increased Hand Washing 2Health News:babyUV/kidsUV inc. Introduces Its kidsUV Surf Team Line of Sun Protection Swim Wear 2Health News:Miami Dade Budget Cuts Leave Needy Families to Fend for Themselves 2
... Surgical Thoracic Trocar consists of ... and a flexible sleeve which ... or laceration to internal structures. ... holes to secure it to ...
... believe that the trocar should be a ... precision and speeding the process. So we ... that meets the needs of the most ... - The only trocar that affords the ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: